Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual trigger comparison for second oocyte retrieval in Dual Stim low responders
2021-001225-43Phase 4Terminated
- Sponsor
- Instituto Bernabeu
- Start
- Sep 2021
- Modality
- Small Molecules, Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of recombinant human chorionic gonadotrophin and triptorelin in female infertility and poor ovarian response (POR) (3 arms), sponsored by Instituto Bernabeu. Primary endpoints: Number of total oocytes obtained in the second cycle of a Dual Stim sequence and Number of mature oocytes (MII) obtained in the second cycle of a Dual Stim sequence. Started Sep 2021; status: terminated.
02
Drugs
recombinant human chorionic gonadotrophintriptorelin
03
Conditions
female infertilitypoor ovarian response (POR)
Beyond the preview
Go deeper on 2021-001225-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001225-43.